These findings suggest that high glucose and inflammation upregulate ACE2 and TMPRSS2, potentially facilitating viral replication and spread, which may worsen COVID-19 severity in patients with diabetes and other inflammatory disorders if the same effects are translated into other organs. This evidence concerns the gene ACE2 and COVID-19.